The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity
| Autor: | Yurij B Kuzminov, Andrij F Faynyk, Olesia Bochar, Helena Y Sklyarova, Volodymyr T Bochar, Andrij Y Bazylevych |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Adiponectin business.industry Atorvastatin 030232 urology & nephrology Hemodynamics General Medicine medicine.disease Obesity 03 medical and health sciences 0302 clinical medicine Blood pressure 030220 oncology & carcinogenesis Internal medicine Heart rate Cardiology medicine Telmisartan Olmesartan business medicine.drug |
| Zdroj: | Wiadomości Lekarskie. 73:321-324 |
| ISSN: | 0043-5147 |
| DOI: | 10.36740/wlek202002122 |
| Popis: | OBJECTIVE The aim: To evaluate the hemodynamic and echocardiographic parameters, the level of adiponectin and IL-6 in such patients under the influence of therapy with sartans (telmisartan or olmesartan) and atorvastatin 12 weeks later. PATIENTS AND METHODS Materials and methods: Fifty patients with arterial hypertension of II stage and 2 level, who underwent elective in-patient treatment were examined. During the next 12 weeks, they took olmesartan (1st group) or telmisartan (2nd group) in combination with atorvastatin. RESULTS Results: The combined use of olmesartan or telmisartan in with atorvastatin for 12 weeks had a resulted in a significant decrease in systolic and diastolic blood pressure, heart rate and myocardial mass. After treatment with olmesartan in combination with atorvastatin, the adiponectin content in the blood increased by 41.6% (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|